Pregabalin Capsule
Product Images NDC 80425-0030
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 80425-0030). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Fig 10
Fig 11
Fig 12
Fig 2
Fig 3
Fig 4
Fig 5
Fig 6
This appears to be a table presenting the results of two different studies (Study E1 and Study E3) comparing different doses of an unknown treatment versus a placebo. The table displays different percentages and numbers indicating the effectiveness of the treatment for different dosages. The text mentions that the results were statistically significant when compared to placebo. However, without additional context or information, it is difficult to determine the exact nature of the treatment or provide a more specific description.*
Fig 7
Fig 9
This appears to be a chart showing the percentage of patients who have improved in pain, categorized based on different doses of a medicine called Pregabalin. There are four categories listed: 100 mg, 300 mg, 450 mg, and a placebo. The chart shows that the highest percentage of improvement is with the 450 mg dose, followed by the 300 mg dose, and then the 100 mg dose. The placebo group shows no improvement.*
Formula
Pregabalin 75mg Cap Qty 60 Ndc 80425 0030
Pregabalin 75mg Cap Qty 90 80425 0030
Structure
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.